Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy  by Xie, Yuansheng et al.
Kidney International, Vol. 65 (2004), pp. 1135–1144
PERSPECTIVES IN RENAL MEDICINE
Relationship between tonsils and IgA nephropathy as well as
indications of tonsillectomy
YUANSHENG XIE, XIANGMEI CHEN, SHINICHI NISHI, ICHIEI NARITA, and FUMITAKE GEJYO
Kidney Center of PLA, Department of Nephrology, Chinese General Hospital of PLA, Beijing, China; and Division of Clinical
Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
Relationship between tonsils and IgA nephropathy as well as
indications of tonsillectomy. Although there are many papers
about IgA nephropathy (IgAN) and tonsils, respectively, re-
views about the relationship between tonsils, tonsillitis, tonsil-
lectomy, and IgAN are limited. In this review, we introduced
the structure, development, and function of tonsils, difference
of tonsils with and without IgAN, consistency of both tonsil-
lar IgA and glomerular IgA, the effect of tonsil stimulation,
tonsil infection, and tonsillectomy on IgAN showed some evi-
dences in which tonsils were closely related to IgAN and poly-
meric IgA1 deposited in glomerular mesangium were at least
in part of tonsillar origin. Tonsillectomy can improve the uri-
nary findings, keep stable renal function, improve mesangial
proliferation and IgA deposit, have a favorable effect on long-
tern renal survival in some IgAN patients, and do not cause
significant immune deficiency and do not increase incidence of
the upper respiratory tract infections, and can be used as a po-
tentially effective treatment. The indications of tonsillectomy
in patients with IgAN include mainly the deterioration of uri-
nary findings after tonsillar infection, mild or moderate renal
damage. However, tonsillectomy may not be enough and may
not change the prognosis in IgAN patients with marked renal
damage.
Immunoglobulin A nephropathy (IgAN), that is,
nephropathy with mesangial IgA-IgG deposits, was first
reported by Berger and Hinglais in Frence in 1968 [1]
and described by Berger in English in 1969 [2]. Studies
for more than 30 years demonstrated that primary IgAN
is an immune complex–mediated glomerulonephritis de-
fined immunohistologically by the presence of glomeru-
lar IgA deposits [3]. It is now generally known to be
the most common form of primary glomerulonephritis
throughout the world [4–6]. Although primary IgAN was
considered a benign condition for many years, it is now
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clear that a large number of cases eventually progress to
renal failure [7–11]. Indeed, IgAN is the main cause of
end-stage renal disease (ESRD) in patients with primary
glomerular disease who require renal replacement ther-
apy [12, 13]. However, the cause of primary IgAN, source
of IgA deposited in glomeruli and the mechanism under-
lying mesangial IgA deposition in IgAN, is unclear and
there is no effective treatment available for patients with
IgAN [14].
The IgA deposited in glomerular mesangium in pa-
tients with IgAN appears to be exclusively of the IgA1
subclass [15] and IgA produced by tonsillar lymphcytes in
patients with IgAN is mainly polymeric IgA1, about half
of patients with IgAN their serum IgA levels increase
[16] and tonsillectomy decreases the levels of serum IgA,
suggesting there is any relationship between tonsils and
IgAN. Recently, we demonstrated that the tonsillectomy
has a favorable effect on long-term renal survival in pa-
tients with IgAN [17].
Although there are many papers about IgAN and ton-
sils, respectively, reviews about the relationship between
tonsils, tonsillectomy, and IgAN are limited. In this re-
view, we introduce the structure, development, and func-
tion of tonsils, difference of tonsils with and without
IgAN, consistency of both tonsillar IgA and glomerular
IgA, the effect of tonsil stimulation, tonsil infection, and
tonsillectomy on IgAN, show some evidences in which
tonsils were closely related to IgAN and polymeric IgA1
deposited in glomerular mesangium were at least in part
of tonsillar origin, and present the indications of tonsil-
lectomy in patients with IgAN.
STRUCTURE, DEVELOPMENT, AND
FUNCTIONS OF TONSILS
Structure of tonsils
Human tonsils include the palatine tonsils, nasopha-
ryngeal tonsil (adenoid), lingual tonsil and the tubal ton-
sils [18] (Fig. 1). The palatine tonsils are the largest ones in
four types of tonsils in human beings. Histologically, tonsil
tissues consist of four well-defined microcompartments,
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Fig. 1. Anatomy of the tonsils.
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Fig. 2. Histologic structure of tonsils. The sample originated from ton-
sil tissues after tonsillectomy because of chronic tonsillitis in 8-year-old,
male patient. The cellular nuclei of the section were stained with hema-
toxylin (original magnification ×50).
which all participate in the immune response: the retic-
ular crypt epithelium, the interfollicular (extrafollicular)
area, the mantle zone of lymphoid follicles, and the fol-
licular germinal center [19] (Fig. 2). Cell biologically, im-
munocyts of tonsil tissues contain predominantly B cells
(approximately 65%), approximately 30% CD3+ T cells,
and 5% macrophages. The T cells were primarily of the
CD4+ subset (approximately 80%) [20]. Quantitative im-
munohistochemistry reveals that IgG-containing B cells
predominate in all lymphoid compartments, including
follicles, extrafollicular areas, and reticular epithelium,
whereas IgA cells are found predominantly in extrafol-
licular areas, especially subepithelial area, and IgM cells
are in follicles. J chain is present within IgM and some IgA
cells. The IgG:IgA:IgM class ratios of the overall tonsillar
immunocyte population are 13:8:2. Cells containing IgD
and IgE are rare [21]. In clinically normal tonsils, the over-
all percentage distribution of these cells is 65:30:3.5:1.2
for the IgG, IgA, IgM. and IgD classes, respectively.
In recurrent tonsillitis, these figures are 53:39:4.7:4.4; in
hyperplastic tonsillitis, 67:25:4.0:4.5; and in idiopathic
tonsillar hyperplasia, 50:33:7.2:10, respectively [22]. In
comparison with the clinically healthy tonsils, the num-
ber, the size of the germinal centers and the density of the
immunocytes in tonsils are very large in the hyperplastic
tonsils, large in chronic cryptic tonsillitis, but remarkably
decreased in acute tonsillitis [23]. The study regarding
the distribution and proportion of Ig subclasses produc-
ing cells in chronic tonsillitis show that the percentage
ratios of IgG1:IgG2:IgG3:IgG4 were 53.1:35.9:4.7:6.3, re-
spectively. Proportional ratios of IgA1:IgA2 are approx-
imately 80:20 [24].
Development of tonsils
The development of the palatine tonsils starts during
the 14th gestational week when the mesenchyme underly-
ing the mucous membrane of the tonsillar cavity becomes
invaded by mononuclear wandering cells. In fetuses of
about the 16th gestational week epithelial crypts grow
down into the connective tissue and are infiltrated by T
lymphocytes. At the same time, precursors of interdigi-
tating cells can be identified among the epithelial cells.
Primary follicles develop in earlier fetal stages than in
all other secondary lymphoid organs. They contain pre-
cursors of dendritic reticulum cells and lymphoid cells
that belong to the B-cell line. These primary follicles may
be considered as the first assemblage of B-cell regions in
human fetal lymphoid tissue [25]. The formation of the
follicular germinal centers reflecting B-cell activation by
exogenous antigens takes place shortly after birth [26].
The immunohistochemical study show the morphomet-
ric features of tonsils below the age of 8 years are more
active than those above the age of 8 years. Total number
of IgA immunocytes is the highest at the age of 5 to 7
years with a decline by age. The serum IgA and salivary
secretory IgA concentrations reach to adult’s level at the
age of 11 to 13 years. These results suggest that tonsils in
preschool children are important as a local immunologi-
cal defense mechanism [27].
Functions of tonsils
Tonsil tissues are located at the gateway of the respi-
ratory and alimentary tract and belong to the mucosa-
associated lymphoid tissue. The generation of B cells in
the germinal centers of the tonsil is one of the most es-
sential tonsillar functions. The major function of tonsils
is as a first line of defense against viral, bacterial, and
food antigens that enter the upper aerodigestive system.
Secretory dimeric IgA produced by B cells has particu-
lar hydrophilic properties and is capable of preventing
adsorption and penetration of bacteria and/or viruses
into the upper respiratory tract mucosa [28]. With the
uptake of antigen by microfold cells (membrane cell, M
cells) present in the cryptepithelium a process is initiated,
which ultimately results in the generation and dissem-
ination of antigen-specific memory and mainly dimeric
IgA-producing effector B lymphocytes. This process re-
quires successful cognate interactions between antigen-
presenting cells and lymphocytes and mutually between
lymphocytes, which depend not only on antigen-specific
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Table 1. Difference of tonsils with (+) and without (−) IgA
nephropathy (IgAN)
Reference
Characteristic of tonsils IgAN(+) IgAN(−) number
T cell area (T nodules) Expanded Not expanded 29
Reticulization of crypt Reduced Not reduced 31
epithelium
IgA cells:IgG cells >1 <1 32–34
Polymeric IgA cells Increased Not changed 32–34
Polymeric IgA:IgA Increased Not changed 35
Follicular dendritic cells IgA1+ IgA1− 36
J chain mRAN-positive cells Increased Not changed 37
Adhesion molecules CD31, Increased Not changed 38
CD54
CD5+ B cells Increased Not changed 39
signals, but also on the expression of various complemen-
tary adhesion and costimulatory molecules [19]. In addi-
tional, Mitogen-triggered T cells from tonsils produced
both of Th1- and Th2-type cytokines, clearly exhibit-
ing their pluripotentiality for support of cell-mediated
and antibody responses. The antigen-specific T cells pro-
duced interferon-gamma (INF-c ) and lower levels of
interleukin-5 (IL-5). These results suggest that tonsils
of the nasopharyngeal-associated lymphoreticular tissues
represent a distinct component of the mucosal-associated
lymphoreticular tissues with features of both systemic
and mucosal compartments [20].
DIFFERENCE OF TONSILS WITH
AND WITHOUT IgA NEPHROPATHY
There are significant differences in histologic structure,
proportional ratios of cells, and cell adhesion molecules
in tonsils with and without IgAN (Table 1).
Difference of tonsillar histologic structure
The enlarged primary T nodules in tonsils, which are
defined as sum of the small areas of accumulating T lym-
phocytes and apparent nodule, composed predominantly
of small T lymphocytes, were a characteristic feature of
tonsils in patients with IgAN. Most T nodules in pa-
tients with IgAN were enlarged, especially in younger
patients, and a few T nodules contain high endothelial
venules and nonlymphoid cells. In contrast, T nodules
in patients with habitual tonsillitis do not expand, and
nonlymphoid cells and high endothelial venules are dis-
tributed peripherally around the nodules [29]. The basic
structure and functional unit of reactive lymph nodes is
composed of two separate T nodules and B-lymphoid
follicles. These composite nodules play a major role in
the triggering, helper T-cell–dependent stimulation and
subsequent maturation of antigen-responsive B cells into
antibody-secreting plasma cells [30]. With regard to his
relationship between T-cell and B-cell domains, the en-
larged primary T nodules reminds us that extrafollicular
maturation of the stimulated B lymphocytes into plasma
cells may occur more frequently in the tonsils of patients
with IgAN than in patients with habitual tonsillitis. An-
other study demonstrated abnormal reticulization of ton-
sillar crypt epithelium in patients with IgAN. Tonsils of
controls with recurrent tonsillitis or tonsillar hypertro-
phy showed well-developed reticular crypt epithelia with
lymphoepithelial symbiosis, and the nonreticulated area
was less than 7% of the total crypt epithelia per overall
section. In IgAN tonsils, however, nonreticulated crypt
epithelium was frequently observed and, in the advanced
stage of IgAN, exceeded 50% of total crypt epithelia [31].
Difference of tonsillar cells
Primary IgAN is characterized by renal deposits of
polymeric IgA (J chain-positive), the origin of which is
not confirmed, yet. The study by Bene et al [32] showed
that in controls with recurrent tonsillitis, IgG secreting
cells were predominant (IgG secreting cells 65% and
IgA plasma cells 29%), while in the IgAN patients, the
plasma cells percentages was of an inversion (IgG 37%
and IgA 56%). This increment in the IgA population was
paralleled by an augmentation of the number of dimeric
IgA secreting cells (75% of IgA plasma cells), stained
both for cytoplasmic IgA and J chain [32]. The study by
Nagy and Brandtzaeg [33] and a later multicenter study
by Bene et al [34] also demonstrated a similar result. In
additional, after 7 days of culture with pokeweed mito-
gen, the percentage of tonsillar cells producing polymeric
IgA is significantly higher in the IgAN patients than in the
controls suffering from chronic tonsillitis [35]. The IgA1
subclass was found in follicular dendritic cells (FDC)
of the tonsil of IgAN patients, but not in FDC of non-
IgAN controls. On the other hand, IgA2, IgG, IgM, and
C3 did not show any differences in distribution between
the two groups [36]. In situ hybridization (ISH) study
for the detection of J chain mRNA within IgA plasma
cells revealed J chain mRNA-positive cells were identi-
fied in germinal centres, and within the subepithelial and
interfollicular zones of tonsils. Combined immunofluo-
rescence and fluorescent ISH showed a greater propor-
tion of J chain mRNA-positive interfollicular IgA cells in
the patient tonsils compared with the controls. In addi-
tional, the finding of excess numbers of J chain-positive
IgA-negative cells was found within germinal centers of
tonsils in IgAN patients [37]. These results demonstrate
immune abnormalities within the tonsil as a central fea-
ture of abnormal polymeric IgA biology in IgAN, which
is in keeping with the hypothesis favoring a tonsil origin
for the mesangial IgA present in their kidneys.
Abnormalities in the partition of IgA- and IgG-
producing cells in the tonsils of patients with IgAN have
been suggested to result from a dysregulation of cell
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trafficking and homing through high endothelial venules
in this lymphoid tissue. Study demonstrated a significant
enhancement of cell adhesion molecules, CD31 and
CD54, expression on high endothelial venules of tonsils
from patients with IgAN compared with controls [38].
In additional, the number of CD5+ B cells isolated from
the tonsil germinal centers of IgAN patients is increased.
These CD5+ B cells are likely IgA1 antibody-producing
cells. Moreover, these CD5+ B cells show a reduced sus-
ceptibility to Fas-mediated apoptosis [39].
RELATIONSHIP BETWEEN TONSILLAR IgA
AND GLOMERULAR IgA
Both IgA produced by tonsil cells and IgA deposited
in glomerular mesangium with IgAN are mainly J chain-
positive polymeric IgA [35, 37, 40, 41]. Studies demon-
strated they were consistent in some cases. The antibodies
eluted from renal tissues of patients with IgAN specifi-
cally bound with the nuclear regions of tonsillar cells.
The binding of eluted antibodies and tonsillar cells was
completely inhibited by the addition of antihuman IgA
antisera, but not inhibited by human IgA myeloma pro-
teins. The eluted antibodies bound with tonsillar cells
from the same patients, but only 10% of them bound
with the tonsillar cells obtained from other patients with
IgAN. This result suggests that IgA antibodies deposited
in glomeruli specifically bind with tonsillar cells obtained
from patients with IgAN [42]. The study by Tokuda et al
[43] offered another evidence of binding of IgA produced
by tonsillar B lymphocytes to the glomerular mesangium
of IgAN. They first made heterohybridoma cells of hu-
man tonsillar B lymphocytes from IgAN patient with
mouse myeloma cells and cultured them. The culture
medium was analyzed by Western blot analysis using an-
tihuman IgA antibody, and both IgA1 and IgA2 were
demonstrated to be produced. The specimens of the biop-
sied kidney tissue of IgAN were washed with 0.02 mol/L
citrate buffer (pH 3.2) to remove deposited IgA from
glomerulus. The specimens were then incubated with the
culture media of hybridoma cells, and immunofluores-
cence analysis using fluorescein isothiocyanate (FITC)-
conjugated antihuman IgA antibody was performed. The
result demonstrated that IgA deposit was efficiently re-
moved by washing with citrate buffer and was recovered
after incubation with the culture medium of hybridoma
cells [43].
TONSIL STIMULATION AND IgAN
Method and judging criteria of tonsil provocation test
The methods of tonsil provocation test include direct
or indirect tonsil stimulation using Tonsil Provocator pro-
ducing an ultrashort wave (each tonsil for 5 minutes), me-
chanical tonsil stimulation (tonsil massage, each tonsil for
5 minutes) and injecting hyaluronidase (2000 U/mL, each
tonsil for 0.5 mL) into tonsils. In general, four criteria are
used to judge the results of tonsil provocation test. Any
one of four criteria positive is regarded as tonsil provo-
cation test positive: (1) an increase of white blood cell
count over 1200/mm3 after 3 hours; (2) an increase in
body temperature over 0.55◦C after 15 minutes; (3) en-
hancement of erythrocyte sedimentation rate over 12 mm
after 1 hour; and (4) worsened skin eruption or deterio-
ration of urinary findings after 3 hours, which is defined
as urinary protein increased by more than 30 mg/dL or
erythrocyte count in the sediment increased by more than
10/hpf, as compared with that before the test [44, 45].
Effect of tonsil stimulation on IgAN
Although the pathogenesis of IgAN still remains un-
certain, it is well known that IgAN patients often show
gross hematuria or deteriorated urinary findings after
upper respiratory tract infections such as tonsillitis, it is
supposed that tonsil inflammatory stimulation may be
related to IgAN. Masuda et al [46] reported that a ten-
dency of decreasing levels of serum complement com-
bined with an increase of CIC was observed within 1 week
after tonsil provocation test in several cases of IgAN as-
sociated with chronic tonsillitis [46]. Shiraishi et al [44]
performed the tonsil provocation test in 11 cases with pus-
tulosis palmaris et plantaris (PPP) and seven cases with
IgAN. Analysis of the provocation test proved positive
in three of 11 cases (27%) with PPP and in five of seven
cases (71%) with IgAN [44]. Yamabe et al [45] studied
effect of ultrashort wave stimulation of tonsils on uri-
nary findings in patients with IgAN. In 62 patients with
IgAN and 20 patients with other renal diseases, tonsils
were directly stimulated by Tonsil Provocator producing
an ultrashort wave to 40.68 MHz each tonsil for 5 minutes.
Forty (65%) of 62 patients with IgAN showed deteriora-
tion of urinary findings after the stimulation compared
with 6 (30%) of 20 patients with other renal diseases. The
deterioration of urinary findings was significantly more
frequent in IgAN than in other renal diseases. In addi-
tional, previous episodes of gross hematuria following
upper respiratory tract infections and the level of serum
secretory IgA were higher in IgAN patients with deteri-
oration of urinary findings after tonsil stimulation than
in those without deterioration [45]. Matsuda et al [47]
evaluated the effects of the mechanical tonsil stimulation
on the serum and urinary concentrations of macrophage-
colony-stimulating factor (M-CSF) in patients with IgAN
associated with chronic tonsillitis. The serum and urinary
levels of M-CSF in the groups with mild and severe IgAN
were significantly higher than those in the chronic tonsil-
litis group without IgAN. Enhanced urinary excretion of
M-CSF prolonged for 7 days after tonsil stimulation in
the severe IgAN group; in contrast, the urinary M-CSF
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level was increased for only 2 days after tonsil stimulation
in the mild IgAN group. The urinary M-CSF level was
not changed in the chronic tonsillitis group after tonsil
stimulation. These results suggest that tonsil stimulation
contributes to the progression of IgAN via enhancement
of glomerular production of M-CSF [47].
However, the usefulness of the tonsillar provocation
test in IgAN is now doubted. Even otolaryngologists [46]
who initially claimed that the tonsillar provocation test
was of clinical value in patients with IgAN have already
changed their opinion. Their late results showed that
there was no statistically significant difference between
positive and negative patients in the rate of remission
of proteinuria based on any parameter of the tonsillar
provocation test at any time after surgery [48, 49]. More-
over, the Japan Society of Stomato-Pharyngology offi-
cially reported the lack of value of tonsillar provocation
test in determining the indications for tonsillectomy in
IgAN patients [50]. We think that an increase of white
blood cell count, an increase of body temperature and
enhancement of erythrocyte sedimentation rate after ton-
sillar provocation test may not be of any clinical value in
patients with IgAN, but deterioration of urinary findings
after tonsillar stimulation may be significant and suggest
that tonsils are related to kidneys. A questionnaire sur-
vey also showed that 51.6% of 154 medical doctors who
had reported case of IgAN answered that urine protein
was the most important factor in any estimation of the
provocation test [51].
TONSILLAR INFECTION AND IgAN
Tonsillar bacterial infection and IgAN
Suzuki et al [52] reported that the antigen and anti-
bodies of outer membranes of Haemophilus parainfluen-
zae, a common bacterium on the tonsils, were present
in glomerular mesangium and sera of IgAN, respectively,
suggesting that H. parainfluenza infection may have a role
in the etiology of IgAN [52]. Further studies showed that
tonsillar lymphocytes from patients with IgAN revealed a
significantly higher stimulation index to H. parainfluenza
antigens (thymidine incorporation in tonsillar lympho-
cytes with H. parainfluenza/thymidine incorporation in
unstimulated tonsillar lymphocytes) than controls. The
lymphocytes from patients with IgAN also showed a
significantly higher level of IgA antibody and IgA1 anti-
body against H. parainfluenza antigens in culture super-
natants than lymphocytes from controls [53]. In vivo study
showed that mouse glomerular deposition of H. parain-
fluenza outer membrane antigens and IgA, and increases
in the amount of mesangial matrix were observed after
administration of H. parainfluenza outer membrane anti-
gens orally or intraperitoneally, respectively. Levels of
IgA antibodies against H. parainfluenza outer membrane
antigens were significantly increased in administration
groups compared with controls. That is, administration of
H. parainfluenza outer membrane antigens to mice may
induce glomerular deposition of IgA and mesangial pro-
liferation, resembling the changes seen in IgAN, with in-
creases in IgA antibodies against H. parainfluenza outer
membrane antigens [54]. Furthermore, production of cy-
tokines IL-10 and transforming growth factor-b (TGF-
b) was enhanced by stimulation with H. parainfluenza
outer membranes in tonsillar mononuclear cells from
IgAN [55]. These results suggest that H. parainfluenza
antigens stimulate tonsillar T and B lymphocytes in pa-
tients with IgAN to produce cytokines and IgA antibody
and that an immune response to H. parainfluenza anti-
gens may play a role in the pathogenesis of IgAN in some
cases.
In additional, Rekola et al [56] reported that 38 of 187
IgAN patients had possible acute glomerulonephritis at
the onset of their disease. Antistreptococcal antibodies
increased in forty-three percent of the patients. Thirty-
three percent of the patients had different groups of beta-
hemolytic streptococci isolated from their throats. This
result indicates a possible role of beta-hemolytic strepto-
cocci, a most common bacterium in tonsils or throat, in
the pathogenesis of some IgAN cases [56].
Tonsillar viral infection and IgAN
Regarding relationship between viral infection in
tonsils and IgAN, there is a adult case report in which
granular depositions of adeno- and herpes simplex vi-
ral antigens were detected in the glomerular mesangial
areas in IgAN patients associated with episodes of re-
current tonsillitis and in the tonsillar epithelial cells by
H. parainfluenza immunofluorescence [57]. The later
study showed that the detection ratio of Epstein-Barr
virus in the patients with glomerular lesions, such as IgAN
and membranous nephropathy, was significantly greater
than those without. However, the detection of Epstein-
Barr virus was not disease specific [58]. Kunimoto et al
[59] investigated viral infections in the tonsils, pharynx,
and renal tissues of patients with IgAN using cell culture,
polymerase chain reaction, and immunofluorescent tech-
niques, and measured antibody titers against numerous
types of viruses. As a result, no evidence was obtained that
the viral infections play a significant role in the pathogen-
esis of IgAN [59].
EFFECT OF TONSILLECTOMY ON IgAN
Effect of tonsillectomy on immune system
As described above, human tonsil tissues are located
at the gateway of the respiratory and alimentary tract,
belong to the mucosa-associated lymphoid tissue, and
play a role in the systemic immune and the local mu-
cosal immune. What effect does tonsillectomy have on
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Table 2. Effect of tonsillectomy on urinary findings and renal function
Author Year Tonsillectomy +/− Follow-up months Urinary remission Urinary improvement Renal survival Reference number
Masuda 1988 16/0 36 56.3% 46
Tamura 1993 26/0 24 46% 71
Sugiyama 1993 28/0 61 32% 60.7% 79
Bene 1993 34/0 48 UP 3.5 g/day → 0.9 g/day Stable 69
Iino 1993 35/15 36 54.8%/53.8% 61%/46% 96.8%/76.9% 78
Tomioka 1996 104/0 12 38% 94% 80
Barta 1996 35/40 144 6m UP 1.4 g/day → 0.92 g/d 88.6%/80.0% 70
Rasche 1999 16/39 41 NS 74
Hotta 2001 250/79 75 Total 48% 81
Xie 2003 48/70 193 89.6%/63.7% 17
Abbreviations are: UP, urine protein; NS, non-statistic difference.
the systemic and local mucosal immune? Studies demon-
strated that tonsillectomy decreased the levels of serum
IgA and salivary secretory IgA, especially in children,
several months or years after operation [60–62]. How-
ever, these changes do not cause significant immune de-
ficiency and are clinically insignificant. Moreover, these
alterations do not increase incidence of immunomodu-
lated diseases, such as infections of the upper respiratory
tract [63]. These may be because the concentrations of
serum IgA and salivary secretory IgA are higher before
operation in some tonsillectomy cases than that of non-
tonsillectomy controls. Tonsillectomy decreased signifi-
cantly the IgA levels compared with preoperation, but
there is no significant difference compared with normal
nonoperative controls [27]. Recent study demonstrated
children with chronic tonsillitis have increased levels of
CD19+ B lymphocytes compared to healthy controls in
the pre-operative period. The percentage of B lympho-
cytes bearing CD23 was found to be significantly higher
in patients, most likely representing in vivo B lymphocyte
activation due to chronic antigenic stimulation. After the
tonsillectomy, despite ongoing B lymphocyte activation,
CD8+ T lymphocyte levels increased and B cell levels
returned to normal [64].
Tonsillectomy may also lead to certain changes in the
cellular immune systems in some boys, including slightly
increased percentages of CD21+ cells, raised counts of
CD4+ cells, absolute and relative increases in DR+ cells
and a raised CD4+DR count [63]. Peripheral blood CD8+
cells, CD45RA+CD4+ cells, and CD8+CD11b− cells in-
crease significantly after tonsillectomy, compared with
their preoperative values in patients with IgAN accom-
panied by chronic tonsillitis. In some cases, the preop-
erative serum tumor necrosis factor-alpha (TNF-a), and
INF-c levels were higher than normal before surgery, but
decreased after surgery. These results suggest that tonsil-
lectomy suppresses a decrease in suppressor T cells in
patients with IgAN and corrects abnormal cell-mediated
immune responses in these patients [65].
In additional, tonsillectomy has no effect on com-
plement and saliva-derived nonimmunoglobulin host
defense factors, such as lysozyme, salivary peroxidases,
thiocyanate, hypothiocyanite, and agglutinins, except
lactoferrin, which declined significantly [66]. The effects
of tonsillectomy on serum and salivary secretory IgG,
IgM, and IgE remain still controversial [67, 68].
Effect of tonsillectomy on urinary finding
and renal function
Studies demonstrated that tonsillectomy can improve
the urinary finding and keep stable renal function in some
patients with IgAN (Table 2). Bene et al [69] followed
up the evolution of urinary protein and serum creatinine
in 34 patients with IgAN, and Barta et al [70] followed
up 35 IgAN patients after tonsillectomy. The urinary
protein and microhematuria decreased significantly from
6 months after tonsillectomy than that before operation,
and no significant variation was observed in the levels of
creatininemia [69]. Furthermore, tonsillectomy stopped
gross hematuria in more than two thirds of patients [70].
Tamura et al [71] reported that 46% IgAN patients with
chronic tonsillitis showed distinct improvement in urinary
findings after the tonsillectomy. Akagi et al [48] followed
up 24 patients with IgAN for more than 2 years after
tonsillectomy. Remission of proteinuria was observed in
41.7% of the patients 6 months after surgery and in 50.0%
2 years after surgery [48]. The clinical remission rate of
urinary finding and the stable renal function rate in ton-
sillectomy patients with IgAN were significantly higher
than that in nontonsillectomy patients [72].
Effect of tonsillectomy on renal histologic findings
A repeat renal biopsy study for 35 patients demon-
strated that renal histologic finding improved distinctly
after the combined therapy of methylprednisolone pulse,
prednisolone, antiplatelet, and tonsillectomy in IgAN pa-
tients [73]. The interval between the first and second
biopsy was 18 to 138 months (mean, 77.1 months) in that
study. Mesangial proliferation and interstitial mononu-
clear cell infiltration were significantly reduced in sec-
ond biopsy specimens. Acute inflammatory glomerular
lesions, such as endocapillary proliferations, glomerular
tuft necrosis, and cellular crescents, were present in 32
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Fig. 3. Effect of tonsillectomy on renal histological findings. This pa-
tient was born in 1952, diagnosed with IgA nephropathy (IgAN) by the
first renal biopsy in 1979, received tonsillectomy in 1982, discovered
hypertension in 1985, and received antihypertensive therapy. The pa-
tient underwent the second biopsy in 1989 and the third biopsy in 2001.
Renal specimen was performed by periodic acid-Schiff (PAS) staining
(original magnification ×50).
patients in first biopsy specimens, whereas these were no
longer present in any of the second biopsy specimens.
Although there was no significant difference in percent-
age of globally sclerotic glomeruli between the first and
second biopsy specimens, the percentage of segmen-
tally sclerotic glomeruli was significantly lower in second
biopsy specimens. The distribution of IgA mesangial de-
posits had diminished in most patients, and no IgA de-
posits were seen in second biopsy specimens from eight
patients. Impact of isolated tonsillectomy on renal histo-
logic findings was unknown. We followed up a repeated
biopsy patient with IgAN and tonsillectomy. He did not
receive other drug therapy except for antihypertension.
The first renal biopsy showed the marked mesangial pro-
liferation, marked IgA deposit in glomerular mesangium,
and almost normal renal tubules and blood vessel. Af-
ter 10 years, the second biopsy showed the moderate
mesangial proliferation, moderate IgA deposit, mild-to-
moderate renal tubular atrophy, and mild arteriole scle-
rosis. The third biopsy after 22 years showed the enlarged
glomeruli, mild mesangial proliferation, negative IgA de-
posit, marked tubular atrophy, and moderate arteriole
sclerosis. The results of this patient demonstrated that
tonsillectomy can improve IgA deposit and mesangial
proliferation and cannot impact renal damage induced
by other causes such as hypertension (Fig. 3).
Effect of tonsillectomy on long-term renal survival
Rasche, Schwarz, and Keller [74] reported that there
was no significant correlation between tonsillectomy and
ESRD by observing 16 IgAN patients with tonsillec-
tomy and 39 patients without tonsillectomy, and intro-
duced that tonsillectomy does not reduce the risk of
developing renal failure [74]. The mean observation time
after renal biopsy was relatively short (3.4 ± 4 years)
in that study. Another study demonstrated that ESRD
was detected in four of 35 IgAN patients after 10 years
after tonsillectomy, in eight patients of 40 nontonsillec-
tomy controls [70]. We [17] followed up 118 patients
with idiopathic IgAN patients, including 48 tonsillectomy
patients and 70 nontonsillectomy patients, for 192.9 ±
74.8 months (48∼326 months). In that study, we used
three different statistical methods, including the chi-
squared test, Kaplan-Meier method with log-rank test,
and Cox regression proportional hazards model in or-
der to establish the efficacy of tonsillectomy in IgAN pa-
tients. Baseline characteristics at the time of renal biopsy,
pathologic finding, and therapy during observation were
not significant different between tonsillectomy and non-
tonsillectomy patients. A mean 15 years after diagnostic
biopsy, only five (10.4%) of 48 tonsillectomy patients en-
tered dialysis, whereas 18 (25.7%) of 70 nontonsillectomy
patients required dialysis, by chi-squared test, P = 0.0393.
Kaplan-Meier analysis showed the renal survival rates of
tonsillectomy patients were statistically higher than those
of non-tonsillectomy (log-rank test, P = 0.0329). For ex-
ample, renal survival rates were 89.6% and 63.7% in the
patients with and without tonsillectomy, respectively, at
240 months after renal biopsy. Cox regression analysis
showed that the relative risk for terminal renal failure in
patients with tonsillectomy was lower compared to non-
tonsillectomy patients (hazard ratio 0.22, 95% CI 0.06 to
0.76, P = 0.0164). The results of these three statistical
analyses were consistent. All revealed that tonsillectomy
had a favorable effect on long-term renal survival in pa-
tients with IgAN [17].
Indications and limitations of tonsillectomy
Tonsillectomy and adenoidectomy procedures are
among the oldest surgical procedures still performed to-
day. Otolaryngologically, the two main indications for
tonsillectomy are upper airway obstruction due to ton-
sillar hypertrophy and recurrent acute or chronic ton-
sillitis. Adenoid hypertrophy with upper airway or eu-
stachian tube obstruction and recurrent acute or chronic
adenoiditis or otitis media are main indications to per-
form an adenoidectomy [75]. Nephrologically, indications
for tonsillectomy are to date still unclear. In fact, many
factors have effect on the efficacy of tonsillectomy in pa-
tients with IgAN, such as urinary finding and grades of
renal damage. In general, the efficacy of tonsillectomy
in patients with hemoturia type IgAN, especially pre-
senting hemoturia after tonsil infection, is good [76]. We
have showed that with a mild renal damage condition,
in which the amount of urine protein excretion was less
than 1.0 g/24 hours and global glomerular sclerosis less
than 25%, none of 26 patients with tonsillectomy needed
dialysis, whereas five (13.2%) of 38 patients without ton-
sillectomy required dialysis [17]. The percentage entering
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dialysis in the tonsillectomy patients with moderate renal
damage, such as urinary protein was more than 1.0 g/24
hours, but global glomerular sclerosis was less than 25%
of total, was less than half of that in the nontonsillec-
tomy patients [17]. On the other hand, the patients with a
marked renal damage, in whom both the amount of urine
protein excretion was more than 1.0 g/24 hours and global
glomerular sclerosis was more than 25% of total or cres-
cent formation was more than 25% of total might develop
renal failure even if tonsillectomy was performed, that is,
tonsillectomy is mainly indicated for patients with mild
or moderate IgAN [17, 77, 78]. Rupture of the glomeru-
lar basement membrane occurred more frequently in the
noneffective tonsillectomy than in the effective tonsillec-
tomy group [79, 80]. Hotta et al [81] conducted a ret-
rospective investigation of the renal outcome in IgAN
patients with a median observation period of 75 months
after tonsillectomy and steroid pulse therapy. Their re-
sults showed that there were no significant differences
between the tonsillectomy and nontonsillectomy groups
regarding the incidence of progressive renal functional
loss defined as a 50% increase in baseline serum crea-
tinine, but a combination of tonsillectomy and steroid
pulse therapy had a significant impact on clinical remis-
sion by multivariate Cox regression analysis [81]. Sato
et al [82] retrospectively investigated 70 patients with ad-
vanced IgAN (serum creatinine ≥1.5 mg/dL) classified
into three groups according to their treatment regimens,
that is, steroid pulse with tonsillectomy (30 patients), con-
ventional steroid (25 patients), and supportive therapy
(15 patients). During the mean follow-up period of 70.3
(12 to 137) months, 41.4% of patients reached ESRD
(13.3% vs. 56.0% vs. 73.3%). The incidence of ESRD in
the patients treated by steroid pulse with tonsillectomy
was significantly lower than that in the patients treated by
conventional steroid and supportive therapy at a baseline
creatinine level of 1.5 to 2 mg/dL, but no statistical dif-
ference was observed at a level of >2 mg/dL [82]. These
results suggest tonsillectomy combined with steroid pulse
therapy may be effective in the IgAN patients with a base-
line creatinine level of ≤2 mg/dL, whereas when serum
creatinine >2 mg/dL, tonsillectomy may not change renal
outcome even if that combines steroid therapy.
CONCLUSION
First, human tonsils are lymphoid organs and play a
role in production of antibodies and local mucosal im-
mune, especially in children. Tonsillectomy decreases the
levels of serum IgA and salivary secretory IgA, but these
changes do not cause significant immune deficiency and
do not increase incidence of the upper respiratory tract
infections. Second, tonsils are closely related to IgAN and
polymeric IgA1 deposited in glomerular mesangium is at
least in part of tonsillar origin. However, it is unclear that
why do IgA-producing cells be predominant in tonsils
with IgAN and how does IgA produced by tonsils de-
posit in mesangium. Third, tonsillectomy can improve the
urinary findings, keep stable renal function, and have a
favorable effect on long-tern renal survival in some IgAN
patients. The indications of tonsillectomy in patients with
IgAN include mainly the deterioration of urinary findings
after tonsillar infection, mild or moderate renal damage.
However, tonsillectomy may not be enough and may not
change the prognosis in IgAN patients with marked renal
damage. Unfortunately, studies regarding tonsillectomy
were performed until now in a retrospective style and lit-
tle information has been available about the side effect
or complication of the operation in IgAN patients. In or-
der to further clarify the clinical efficacy and security of
tonsillecteomy, randomized prospective controlled trials
are necessary because of the high degree of variability of
IgAN.
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